Recombinant monoclonal antibodies bind specific molecular targets and, subsequently, induce an immune response or inhibit the binding of other ligands. However, monoclonal antibody functionality and half-life may be reduced by the type and distribution of host-specific glycosylation. Attempts to produce superior antibodies have inspired the development of genetically modified producer cells that synthesize glyco-optimized antibodies. Glycoengineering typically requires the generation of a stable knockout or knockin cell line using methods such as clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9. Monoclonal antibodies produced by engineered cells are then characterized using mass spectrometric methods t...
Chinese Hamster Ovary (CHO) cells have proven to be a remarkable tool in the production of monoclona...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Abstract Therapeutic antibodies are decorated with complex-type N-glycans that significantly affect ...
Since 2015 more than 39 biosimilars have been approved by the FDA, with over 20 launched, providing ...
Antibody drug conjugates (ADCs) combine the unique specificity of antibodies with the substantial cy...
N-linked glycosylation in monoclonal antibodies (mAbs) is crucial for structural and functional prop...
For more than 20 years, the industry has mainly invested in productivity enhancements. Recently, the...
Glycosylation is one of the most important post-translational modifications that affects proteins’ f...
Gene therapy approaches now allow for the production of therapeutic antibodies by healthy or cancero...
Glycosylation can significantly affect the efficacy of recombinant therapeutics. Glycoprotein drugs,...
One critical quality attribute of therapeutic antibodies is the glycosylation pattern at the Fc regi...
Chinese hamster ovary (CHO) cells are the workhorse of the multibillion-dollar biopharmaceuticals in...
Since the first use of Chinese hamster ovary (CHO) cells for recombinant protein expression, product...
Variability in the glycosylation profile of therapeutic monoclonal antibodies (mAbs), due to recombi...
Monoclonal antibodies (mAbs) are constantly gaining importance as a major class of recombinant prote...
Chinese Hamster Ovary (CHO) cells have proven to be a remarkable tool in the production of monoclona...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Abstract Therapeutic antibodies are decorated with complex-type N-glycans that significantly affect ...
Since 2015 more than 39 biosimilars have been approved by the FDA, with over 20 launched, providing ...
Antibody drug conjugates (ADCs) combine the unique specificity of antibodies with the substantial cy...
N-linked glycosylation in monoclonal antibodies (mAbs) is crucial for structural and functional prop...
For more than 20 years, the industry has mainly invested in productivity enhancements. Recently, the...
Glycosylation is one of the most important post-translational modifications that affects proteins’ f...
Gene therapy approaches now allow for the production of therapeutic antibodies by healthy or cancero...
Glycosylation can significantly affect the efficacy of recombinant therapeutics. Glycoprotein drugs,...
One critical quality attribute of therapeutic antibodies is the glycosylation pattern at the Fc regi...
Chinese hamster ovary (CHO) cells are the workhorse of the multibillion-dollar biopharmaceuticals in...
Since the first use of Chinese hamster ovary (CHO) cells for recombinant protein expression, product...
Variability in the glycosylation profile of therapeutic monoclonal antibodies (mAbs), due to recombi...
Monoclonal antibodies (mAbs) are constantly gaining importance as a major class of recombinant prote...
Chinese Hamster Ovary (CHO) cells have proven to be a remarkable tool in the production of monoclona...
Exerting control over the glycan moieties of antibody therapeutics is highly desirable from a produc...
Abstract Therapeutic antibodies are decorated with complex-type N-glycans that significantly affect ...